ArticleJournal of cellular and molecular medicine2020

Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes.

Rosalinda Madonna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.